+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hepatocyte-specific magnetic resonance imaging contrast agents



Hepatocyte-specific magnetic resonance imaging contrast agents



Hepatology 53(2): 678-682




(PDF emailed within 0-6 h: $19.90)

Accession: 053520029

Download citation: RISBibTeXText

PMID: 21274888

DOI: 10.1002/hep.24158


Related references

The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. Seminars in Ultrasound, Ct, and Mr 34(1): 44-53, 2013

Practical use and pitfalls of hepatocyte-specific contrast agents (HSCAs) for pediatric hepatic and biliary magnetic resonance imaging. Abdominal Radiology (): -, 2016

A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine. Canadian Association of Radiologists Journal 68(3): 293-307, 2017

Evaluation of hepatic contrast enhancement with a hepatocyte-specific magnetic resonance imaging contrast agent (gadoxetic acid) in healthy dogs. American Journal of Veterinary Research 76(3): 224-230, 2015

Metalloporphyrin magnetic resonance contrast agents. Feasibility of tumor-specific magnetic resonance imaging. Acta Radiologica. Supplementum 374: 75-79, 1990

Conclusive HCC diagnosis with hepatocyte-specific contrast-enhanced magnetic resonance imaging? Not yet. Journal of Hepatology 65(3): 648-649, 2016

Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging. Journal of Medicinal Chemistry 47(14): 3629-3641, 2004

Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging. Journal of Hepatology 64(5): 1099-1107, 2016

A Hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 Contrast Agent for Liver Magnetic Resonance Imaging. Molecular Imaging and Biology 17(4): 497-503, 2016

Effects of magnetic resonance imaging contrast agents on human umbilical vein endothelial cells and evaluation of magnetic resonance imaging contrast media-triggered transforming growth factor-beta induction in dermal fibroblasts (HSF) as a model for nephrogenic systemic fibrosis. Investigative Radiology 46(1): 71-76, 2011

Magnetic resonance imaging. Liver-specific contrast agents. Clinics in Liver Disease 6(1): 73-90, 2002

Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging. Current Molecular Imaging 1(1): 12-25, 2013

Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?. World Journal of Gastroenterology 22(1): 284-299, 2016

Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. European Journal of Radiology 82(1): 75-84, 2013

Liposomes as carriers for paramagnetic gadolinium chelates as organ specific contrast agents for magnetic resonance imaging (MRI). Journal of Liposome Research 4(2): 837-855, 1994